Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Martti Huuhka"'
Autor:
Martti Huuhka, Eija Setälä-Soikkeli, Ari Illi, Esa Leinonen, Nina Mononen, Terho Lehtimäki, Olli Kampman, Merja Viikki, Sami Anttila
Publikováno v:
Neuroscience Letters. 477:105-108
Antidepressive medication and electroconvulsive therapy (ECT) increase hippocampal neurogenesis by promoting expression of trophic factors, including brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF). The aims wer
Autor:
Martti Huuhka, Timo Nuolivirta, Sami Anttila, Ari Illi, Esa Leinonen, Merja Viikki, Olli Kampman, Terho Lehtimäki, Nina Mononen, Outi Poutanen, Eija Setälä-Soikkeli
Publikováno v:
Neuroscience Letters. 468:80-84
The association between the tryptophan hydroxylase 1 (TPH1) 218A/C polymorphism and (1) severity of major depressive disorder (MDD) and (2) response to treatment was studied. There were three study populations, the first consisting of 119 treatment-r
Autor:
Sami Anttila, Esa Leinonen, Terho Lehtimäki, Martti Huuhka, Heini Huhtala, Merja Viikki, Riikka Rontu, Kaija Huuhka
Publikováno v:
Neuroscience Letters. 464:43-46
The association of two tryptophan hydroxylase 2 (TPH2) polymorphisms and treatment response in electroconvulsive therapy (ECT) and the risk of depression was studied. The patient sample consisted of 119 subjects with treatment-resistant major depress
Autor:
Martti Huuhka, Nina Mononen, Esa Leinonen, Heini Huhtala, Jarmo Hietala, Kaija Huuhka, Sami Anttila, Terho Lehtimäki
Publikováno v:
Neuroscience Letters. 448:79-83
Alterations in dopamine levels and dopamine receptors in brain are suggested to be associated with treatment response in electroconvulsive therapy (ECT). Dopamine 2 receptor gene (DRD2) polymorphism C957T (rs6277) and cathechol-o-methyltransferase (C
Autor:
Kari M. Mattila, Esa Leinonen, Martti Huuhka, Olli Kampman, Kaija Huuhka, Sami Anttila, Terho Lehtimäki, Riikka Rontu, Mikko Hurme
Publikováno v:
Neuroscience Letters. 437:25-28
We studied the association between RGS4 (rs951436) polymorphism and treatment response in electroconvulsive therapy (ECT) as well as risk of treatment-resistant depression. The study sample consisted of 119 patients with major depressive disorder (MD
Autor:
Esa Leinonen, Martti Huuhka, Riikka Rontu, Sami Anttila, Terho Lehtimäki, Kaija Huuhka, Kari M. Mattila
Publikováno v:
Journal of Neural Transmission. 114:461-468
We studied the association between tryptophan hydroxylase 1 (TPH1) A218C and G-protein beta-3 subunit (GNB3) C825T polymorphisms and treatment response in electroconvulsive therapy (ECT). The sample consisted of 119 patients with major depressive dis
Autor:
Pirjo Saransaari, Jaana Suhonen, Esa Leinonen, Simo S. Oja, Martti Huuhka, Jukka Peltola, Tapani Keränen, Johanna Palmio
Publikováno v:
Psychiatry Research. 137:183-190
There are indications that mood disorders may be related to perturbations in the amino acid transmitters. The amino acids may thus be targets of treatment of depression. The purpose of this pilot study was to measure the acute effects of a single adm
Autor:
Kari M. Mattila, Esa Leinonen, Riikka Rontu, Kaija Huuhka, Heini Huhtala, Terho Lehtimäki, Martti Huuhka, Sami Anttila
Publikováno v:
The Journal of ECT. 21:7-11
The apolipoprotein E (APOE) polymorphism is associated with neurodegenerative diseases. Its role regarding psychiatric disorders is controversial. It has been suggested to affect antidepressant treatment response and response to electroconvulsive the
Autor:
Martti Huuhka, Merja Viikki, Nina Mononen, Olli Kampman, Kaija Järventausta, Esa Leinonen, Terho Lehtimäki
Publikováno v:
Psychiatric Genetics. 23:134-136
The aim of the present study was to test for a possible association between two brain-derived neurotrophic factor (BDNF) polymorphisms (rs11030101 and rs61888800) and the efficacy of electroconvulsive therapy (ECT) [change in Montgomery-Åsberg Depre
Publikováno v:
European Journal of Pain. 8:371-376
The effect of electroconvulsive therapy (ECT) on depression and other symptoms of fibromyalgia was studied in a prospective 3-month trial in 13 patients with fibromyalgia and concomitant depression. All the patients met the DSM-IV diagnostic criteria